Literature DB >> 21862494

Human cerebral microcirculation and oxygen saturation during propofol-induced reduction of bispectral index.

K U Klein1, K Fukui, P Schramm, A Stadie, G Fischer, C Werner, J Oertel, K Engelhard.   

Abstract

BACKGROUND: Propofol reduces cerebral blood flow (CBF) secondary to cerebral metabolic depression. However, in vitro and in vivo studies demonstrate that propofol directly dilates the vascular smooth muscle. This study investigates the effects of propofol-induced changes in bispectral index (BIS) on cerebral microcirculation and oxygenation during craniotomies.
METHODS: In 21 craniotomy patients undergoing routine craniotomy, anaesthesia was maintained with propofol 4-10 mg kg⁻¹ h⁻¹ and remifentanil 0.1-0.4 µg kg⁻¹ min⁻¹. Propofol concentration was adjusted to achieve higher BIS (target 40) or lower BIS (target 20). Regional measurements of capillary venous blood flow (rvCBF), oxygen saturation (srvO₂), and haemoglobin amount (rvHb) at 2 mm (grey matter) and 8 mm (white matter) cerebral depth were randomly performed at higher and lower BIS by combined laser-Doppler flowmetry and spectroscopy. Calculations: approximated arteriovenous difference in oxygen content (avDO₂) and cerebral metabolic rate of oxygen (aCMRO₂).
RESULTS: mean values (sd). STATISTICS: Mann-Whitney test (*P<0.05). Results Human cerebral microcirculation and oxygen saturation were assessed at propofol dosages 5.1 (2.3) mg kg⁻¹ h⁻¹ [BIS 40 (9)] and 7.8 (2.1) mg kg⁻¹ h⁻¹ [BIS 21 (7)]. Propofol-induced reduction in BIS resulted in increased srvO₂ (P=0.018), and decreased avDO₂ (P=0.025) and aCMRO(2) (P=0.022), in 2 mm cerebral depth, while rvCBF and rvHb remained unchanged. In 8 mm cerebral depth, srvO₂, rvCBF, rvHb, and also calculated parameters avDO₂ and aCMRO₂ remained unaltered.
CONCLUSIONS: Findings suggest alteration of the CBF/CMRO₂ ratio by propofol in cortical brain regions; therefore, it might be possible that propofol affects coupling of flow and metabolism in the cerebral microcirculation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862494     DOI: 10.1093/bja/aer227

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Perioperative Cerebral Oxygenation Metabolism in Neonates with Hypoplastic Left Heart Syndrome or Transposition of the Great Arteries.

Authors:  Felix Neunhoeffer; Michael Hofbeck; Christian Schlensak; Martin Ulrich Schuhmann; Jörg Michel
Journal:  Pediatr Cardiol       Date:  2018-08-25       Impact factor: 1.655

2.  Neural correlates of successful semantic processing during propofol sedation.

Authors:  Ram M Adapa; Matthew H Davis; Emmanuel A Stamatakis; Anthony R Absalom; David K Menon
Journal:  Hum Brain Mapp       Date:  2013-10-18       Impact factor: 5.038

3.  Comparison of the Effects of Propofol and Sevoflurane Anesthesia on Optic Nerve Sheath Diameter in Robot-Assisted Laparoscopic Gynecology Surgery: A Randomized Controlled Trial.

Authors:  Jung Eun Kim; Seong Yoon Koh; In-Jung Jun
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

4.  Effects of propofol versus sevoflurane on cerebral oxygenation and cognitive outcome in patients with impaired cerebral oxygenation.

Authors:  Jun-Ying Guo; Jie-Yu Fang; San-Rong Xu; Ming Wei; Wen-Qi Huang
Journal:  Ther Clin Risk Manag       Date:  2016-01-18       Impact factor: 2.423

Review 5.  Laser application in neurosurgery.

Authors:  Evgenii Belykh; Kaan Yagmurlu; Nikolay L Martirosyan; Ting Lei; Mohammadhassan Izadyyazdanabadi; Kashif M Malik; Vadim A Byvaltsev; Peter Nakaji; Mark C Preul
Journal:  Surg Neurol Int       Date:  2017-11-09

6.  Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation.

Authors:  Cecilia Maria Veraar; Harald Rinösl; Karina Kühn; Keso Skhirtladze-Dworschak; Alessia Felli; Mohamed Mouhieddine; Johannes Menger; Ekaterina Pataraia; Hendrik Jan Ankersmit; Martin Dworschak
Journal:  Crit Care       Date:  2019-12-30       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.